Joseph J Wolk Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 10 hours ago
Joseph J Wolk has an estimated net worth of at least $16.2 million*, as of Feb. 19, 2025. They own 74,180 shares of JNJ stock. They have sold 27,796 shares of JNJ stock since 2021, for an estimated $4.7 million.
Joseph J Wolk $JNJ SEC Form 4 Insider Trading
Joseph J Wolk has filed a total of 3 insider trades in $JNJ since 2021. Their most recent trade was a sale of 13,015 shares, made on Feb 07, 2025. Their largest trade was a sale of 13,015 shares, made on Feb 07, 2025. We estimate that they now own 74,180 shares of $JNJ, worth an estimated $11.6 million.
Insider Trading at $JNJ
There have been a total of 349 insider trades reported at $JNJ since 2021, with 1,000 shares purchased and 650,476 shares sold. The most active insider traders in $JNJ stock have been Peter Fasolo, Thibaut Mongon, and William Hait. The most recent trade was a sale of 403 shares reported by Timothy Schmid (EVP, WW Chair, MedTech), made on Feb 18, 2025.
History of Insider Stock Trades by Joseph J Wolk
$JNJ Executives and Stock Owners with Insider Trades
-
Peter Fasolo, Exec VP, Chief HR Officer
-
Thibaut Mongon, Exec VP, WW Chair, Consumer
-
William Hait, See Remarks
-
Kathryn E Wengel, EVP, Chief GSC Officer
-
Joseph J Wolk, Exec VP, CFO
-
Robert J Decker, Controller, CAO
-
Ashley Mcevoy, EVP, WW Chair, MedTech
-
Jennifer L Taubert, EVP, WW Chair, Pharmaceuticals
-
James D. Swanson, See Remarks
-
Kathryn E Wengel, EVP, Chief TO and Risk Officer
-
Robert J Decker, VP Corporate Controller
-
Timothy Schmid, EVP, WW Chair, MedTech
-
Vanessa Broadhurst, EVP, Global Corp Affairs
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.